Prednisolone measurement in human serum using liquid chromatography tandem spectrometry

Annals of Clinical Biochemistry

Volumn 42, Issue 2, 2005, Pages 105-111

  Owen, L J ^a   Gillingwater, S ^b   Keevil, B G ^a  

^a WYTHENSHAWE HOSPITAL   (United Kingdom)

^b MICROMASS UK LTD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PREDNISOLONE;

ACCURACY; ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DETERMINATION; HUMAN; LIQUID CHROMATOGRAPHY; MEASUREMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; PREDNISOLONE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 17144404604     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1258/0004563053492810     Document Type: Article

References (14)

1. Lewis GP, Jusko WJ, Burke CW, Groves L. The Boston Collaborative Drug Surveillance Program: prednisolone side effects and serum protein levels. Lancet 1971; 2: 778-9
2. Brooks PM, Buchanan WW, Grove M, Downie WW. Effects of enzyme induction on metabolism of prednisolone. Ann Rheum Dis 1976; 35: 339-43
3. Petereit LB, Mietkle AW. Effectiveness of prednisolone during phenytoin therapy. Clin Pharmacol Ther 1977; 22: 912-6
4. Kozower M, Veatch L, Kaplan MM. Decreased clearance of prednisolone, a factor in the development of corticosteroid side effects. J Clin Endocrinol Metab 1974; 38: 407-12
5. Luippold G, Schneider S, Marto M, Benohr P, Mulbauer B. Pharmacokinetics of two oral prednisolone tablet formulations in healthy volunteers. Arzneimittelforschung 2001; 51: 911-5
6. Potter JM, McWhinney BC, Sampson L, Hickman PE. Area-under-the-curve monitoring of prednisolone for dose optimization in a stable renal transplant population. Ther Drug Monitor 2004; 26: 408-14
7. Shibata N, Hayakawa T, Takada K, Hoshino N, Minouchi T, Yamaji A. Simultaneous determination of glucocorticoids in plasma or urine by high-performance liquid chromatography with pre-column derivatization by 9-anthroyl nitrile. J Chromatogr B 1998; 706: 191-9
8. Jusko WJ, Pyszczynski NA, Bushway MS, D'Ambrosio R, Mis SM. Fifteen years of operation of a high-performance liquid chromatographic assay for prednisolone, cortisol and prednisolone in plasma. J Chromatogr B 1994; 658: 47-64
9. Majid O, Akhlaghi F, Lee T, Holt DW, Trull A. Simultaneous determination of plasma prednisolone, prednisone and cortisol levels by high-performance liquid chromatography. Ther Drug Monitor 2001; 23: 163-8
10. Delahaut PH, Jacquemin P, Colemonts Y, Dubois M, De Graeve J, Deluyker H. Quantitative determination of several synthetic corticosteroids by gas chromatography-mass spectrometry after purification by immunoaffinity chromatography. J Chromatogr B 1997; 698: 203-15
11. Noé S, Böhler J, Keller E, Fram AW. Determination of prednisolone in serum: method development using solid-phase extraction and micellar electrokinetic chromatography. J Pharm Biomed Anal 1998; 18: 471-6
12. Frerichs VA, Tornatore KM. Determination of glucocorticoids prednisone, prednisolone, dexamethasone and cortisol in human serum using liquid chromatography coupled to tandem mass spectrometry. J Chromatogr B 2004; 802: 329-38
13. Guidance for Industry. Bioanalytical Method Validation. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER) and Center for Vetinary Medicine (CVM), May 2001
14. Annesley TM. Ion suppression in mass spectrometry. Clin Chem 2003; 49: 1041-4.